Best-a
Commercial- Indications
- Corn drought stress
Company intelligence / Profile preview
Elicit Plant is a French agri-biotechnology company founded in 2017 that develops proprietary phytosterol-based biosolutions designed to help broadacre crops withstand environmental stresses such as drought and water scarcity. Its flagship technology platform EliTerra® enables the development of biologic products like BEST-a that have demonstrated significant yield improvements (~12%) under real-world conditions across multiple continents. The company's commercial footprint spans Europe—including France and Ukraine—Brazil/South America, North America/U.S., with ongoing expansion supported by major partnerships with Bayer and BASF among others. Backed by leading investors including Sofinnova Partners and Carbyne Equity Partners following a €45 million funding round announced November 2024, Elicit Plant positions itself at the forefront of sustainable agriculture innovation but does not operate within traditional healthcare/life sciences sectors.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elicit Plant.